In the latest trading session,, 0.6 million Revance Therapeutics Inc (NASDAQ:RVNC) shares changed hands as the company’s beta touched 1.11. With the company’s most recent per share price at $4.07 changed hands at -$0.06 or -1.33% at last look, the market valuation stands at $424.70M. RVNC’s current price is a discount, trading about -833.17% off its 52-week high of $37.98. The share price had its 52-week low at $4.10, which suggests the last value was -0.74% down since then. When we look at Revance Therapeutics Inc’s average trading volume, we note the 3-month average coming to 1.76 million.

Revance Therapeutics Inc (NASDAQ:RVNC) trade information

Instantly RVNC was in red as seen in intraday trades today. With action -8.43%, the performance over the past five days has been red. The drop to weekly highs of 4.94 subtracted -1.33% to the stock’s daily price. The company’s shares are showing year-to-date downside of -53.64%, with the 5-day performance at -8.43% in the red. However, in the 30-day time frame, Revance Therapeutics Inc (NASDAQ:RVNC) is -24.95% down. Looking at the short shares, we see there were N/A shares sold at short interest cover period of N/A days.

Revance Therapeutics Inc (RVNC) estimates and forecasts

Data shows that the Revance Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -51.49% over the past 6 months, a 43.34% in annual growth rate that is considerably higher than the industry average of 13.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0.57%. The 2024 estimates are for Revance Therapeutics Inc earnings to increase by 23.04%, but the outlook for the next 5-year period is at 11.60% per year.